A new study, however by the universities of Manchester, Nottingham, Edinburgh and Dundee, published in the BMJ, has found that antipsychotic drugs prescribed to dementia patients cause more ... light ...

Managing dementia in the complex landscape of neurological disorders stands out as a formidable challenge, affecting millions ...

They found a three-fold increase in the risk of stroke with risperidone when used in older patients with dementia, and a similar risk with olanzapine. The CSM said that while these drugs were ...

The use of SGLT2 inhibitors vs DDP-4 inhibitors is associated with a reduced risk of developing different types of dementia.

Dementia with Lewy bodies ... so the discovery that commonly used drugs may reduce the risk of the disease is a beacon of hope for patients and their carers. The main finding of the observational ...

The rate of antipsychotic drug use in nursing homes has remained stubbornly high. Experts are concerned about misuse.

The time of day when blood is taken can affect the results of tests for diagnosing dementia, according to new research led by ...

A synthetic form of the active ingredient in cannabis helps reduce agitation in people with Alzheimer's, new research shows.

Memory loss is the most well-known symptom of dementia, particularly Alzheimer’s disease. But experts say there are other ...

SGLT2 inhibitors and dulaglutide are associated with comparable risk for dementia; however, it is uncertain whether these findings generalize to newer GLP-1 RAs.

Among the adverse effects reported in the trial, infusion-related reactions were observed in 26.4% of patients in the ...

The health service is supposed to offer people with dementia and their carers advice about how to seek support following a diagnosis. This could include pointing patients to benefits like ...